LPA Receptor Antagonist
Lysophosphatidic acid (LPA) receptor antagonists are compounds that inhibit the activation or signaling of LPA receptors, which belong to the G protein-coupled receptor (GPCR) family. LPA receptors are activated by lysophospholipids, particularly LPA, which is involved in various cellular processes such as cell proliferation, survival, migration, and differentiation. LPA receptors transmit signals through intracellular pathways including G proteins and downstream effectors such as Rho, Ras, and PI3K/Akt. Antagonists of LPA receptors competitively bind to the receptor, preventing LPA from binding and activating downstream signaling pathways. This blockade can potentially be used in therapeutic strategies targeting diseases where LPA signaling is dysregulated, including fibrosis, cancer metastasis, and neuropathic pain. Research into LPA receptor antagonists continues to explore their therapeutic potential and safety profiles in various pathological conditions.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:2 Page 1 of 1 1
